• 1. Department of Thoracic Surgery, Shaanxi People's Hospital, Xi'an, 710068, P.R.China;
  • 2. Department of Cardiovascular Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710068, P.R.China;
LV Shanshan, Email: lvshan2007@163.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate the efficacy and safety of total thoracoscopic lobectomy for patients with stage Ⅰ/Ⅱ non-small cell lung cancer (NSCLC). Methods  The clinical data of 138 NSCLC patients from January 2013 to June 2015 in Shaanxi People's Hospital were retrospectively analyzed. There were 88 males and 50 females with an average age of 57.4±8.8 years, ranging from 44 to 76 years. According to the operation methods, they were divided into a video-assisted thoracoscopic surgery (VATS) group (thoracoscopic lobectomy in 63 cases) and a thoracotomy group (conventional open chest surgery in 75 cases). The intra- and postoperative clinical data, surgical complications and pulmonary function were compared. Results  There was no significant difference in the operation time, intraoperative lymph node dissection groups, intraoperative lymph node dissection number between two groups (P>0.05). The blood loss, postoperative drainage volume, duration of postoperative analgesia, Numeric Rating Scale for pain and hospital stay in the VATS group were significantly lower than those of the thoracotomy group (P<0.05). The pre- and postoperative FVC%pred and FEV1%pred in both groups were compared and there was no significant difference (P>0.05). However the postoperative FVC%pred and FEV1%pred in both groups significantly reduced compared with preoperative ones (P<0.05). Complication rate of thoracoscopic group was significantly less than that of the thoracotomy group (20.63%vs. 32.00%,χ2=3.974,P=0.046). Conclusion  Thoracoscopic lobectomy for NSCLCⅠ/Ⅱpatients is reliable, and achieves rapid postoperative recovery as well as less complications.

Citation: DOU Yawei, LV Shanshan, TIAN Wei, WANG Hongtao, ZHU Jianfei, DAI Yun, LUO Xianghui. Outcome of thoracoscopic lobectomy for stageⅠ/Ⅱnon-small cell lung cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2017, 24(3): 192-195. doi: 10.7507/1007-4848.201607031 Copy

  • Previous Article

    Relationship between preoperative risk score for esophageal cancer (PRSEC) and prognosis after resection of esophageal carcinoma
  • Next Article

    Surgical treatment of tracheal or bronchial stenosis related to severe congenital heart disease